Cytokine-mediated regulation of activating and inhibitory Fcγ receptors in human monocytes

被引:50
作者
Liu, Y
Masuda, E
Blank, MC
Kirou, KA
Gao, X
Park, MS
Pricop, L
机构
[1] Cornell Univ, Weill Med Coll, Hosp Special Surg, Div Res, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Grad Program Immunol, New York, NY 10021 USA
关键词
phagocytes; hypersensithity; inflammation;
D O I
10.1189/jlb.0904532
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Fc gamma receptors (Fc gamma R) trigger inflammatory reactions in response to immunoglobulin-opsonized pathogens and antigen-antibody complexes. The coordinate expression of activating and inhibitory Fc gamma R ensures the homeostasis of immune complex-driven inflammatory responses. In this study, we used antibodies with preferential binding for activating Fc gamma RIIa and inhibitory Fc gamma RIIb receptors to investigate the expression and regulation of Fc gamma RII isoforms in human monocytes. Cross-linking of Fc gamma RIIa triggered phagocytosis and cytokine production. Cross-linking of Fc gamma RIIb was associated with phosphorylation of the immunoreceptor tyrosine-based inhibitory motif and with a marked reduction in monocyte effector functions. Our study revealed that tumor necrosis factor alpha (TNF-alpha), interleakin (IL)-10, and IL-13 altered the transcriptional activity of the Fc gamma RIIB promoter in transfected cell lines and skewed the balance of activating versus inhibitory Fc gamma R in human monocytes. TNF-alpha decreased the expression of inhibitory Fc gamma RIIb. IL-10 up-regulated all classes of Fc gamma R and induced alternative activation in monocytes, an effect that was synergistic with that of TNF-alpha. In contrast, IL-4 and IL-13, in combination with TNF-alpha, decreased the expression of activating Fc gamma R and markedly down-regulated Fc gamma R-mediated function. Our findings suggest that the cytokine milieu can induce changes in the relative expression of Fc gamma R with opposing function and thus, may regulate the amplitude of Fc gamma R-mediated uptake and inflammation.
引用
收藏
页码:767 / 776
页数:10
相关论文
共 50 条
[1]   Cytokines and anti-cytokine biologicals in autoimmunity: present and future [J].
Andreakos, ET ;
Foxwell, BM ;
Brennan, FM ;
Maini, RN ;
Feldmann, M .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :299-313
[2]  
ASTIER A, 1994, J IMMUNOL, V152, P201
[3]  
BRENNAN FM, 1989, LANCET, V2, P244
[4]   STRUCTURE AND EXPRESSION OF HUMAN-IGG FCRII(CD32) - FUNCTIONAL-HETEROGENEITY IS ENCODED BY THE ALTERNATIVELY SPLICED PRODUCTS OF MULTIPLE GENES [J].
BROOKS, DG ;
QIU, WQ ;
LUSTER, AD ;
RAVETCH, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1369-1385
[5]   Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease [J].
Bruhns, P ;
Samuelsson, A ;
Pollard, JW ;
Ravetch, JV .
IMMUNITY, 2003, 18 (04) :573-581
[6]   Differentiation of the human monocyte cell line, U937, with dibutyryl cyclicAMP induces the expression of the inhibitory Fc receptor, FcγRIIb [J].
Cameron, AJM ;
McDonald, KJ ;
Harnett, MM ;
Allen, JM .
IMMUNOLOGY LETTERS, 2002, 83 (03) :171-179
[7]   FcγRIIB is differentially expressed during B cell maturation and in B-cell lymphomas [J].
Camilleri-Broët, S ;
Cassard, L ;
Broët, P ;
Delmer, A ;
Le Touneau, A ;
Diebold, J ;
Fridman, WH ;
Molina, TJ ;
Sautès-Fridman, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (01) :55-62
[8]   Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells [J].
Cassard, L ;
Cohen-Solal, JFG ;
Galinha, A ;
Sastre-Garau, X ;
Mathiot, C ;
Galon, J ;
Dorval, T ;
Bernheim, A ;
Fridman, WH ;
Sautès-Fridman, C .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (10) :1549-1557
[9]  
CHERNOFF AE, 1995, J IMMUNOL, V154, P5492
[10]   Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors [J].
Clynes, R ;
Maizes, JS ;
Guinamard, R ;
Ono, M ;
Takai, T ;
Ravetch, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :179-185